Effect of Agave Consumption on Performance and Gut Microbiota in Adults Undergoing Physical Training
1 other identifier
interventional
12
1 country
1
Brief Summary
The purpose of this study is to analyze changes in the gut microbiota of healthy adult athletes, both men and women, before and after supplementation with a dietary fiber (agavins). Each participant will be their own control, so the design will allow us to identify whether the intervention generates changes in bacterial composition and whether these changes are related to variations in physical performance. The study will determine changes in the gut microbiota, athletic performance, and markers of metabolic stress such as lactate and creatine kinase. Volunteers will be required to take 10g of agavins in warm water for 6 weeks. The gut microbiota will be evaluated through a stool sample, while athletic performance will be measured through direct calorimetry, determining VO2max. Lactate will be determined by finger prick using Accutrend Plus equipment, while creatine kinase will be measured using a blood sample taken by staff from the biomarker measurement laboratory of the Department of Nutrition and Functional Foods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 6, 2025
CompletedFirst Submitted
Initial submission to the registry
August 14, 2026
CompletedFirst Posted
Study publicly available on registry
September 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 11, 2027
September 18, 2026
September 1, 2026
1.7 years
August 14, 2026
September 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in the relative abundance of gut microbiota bacterial taxa determined by multiplex digital PCR
The relative abundance of selected gut microbiota bacterial taxa will be determined from fresh fecal samples collected at baseline and after 6 weeks of supplementation using multiplex digital PCR and reported as percentages of the total bacterial population.
Before and after agavin supplementation, which lasts 6 weeks
Secondary Outcomes (3)
Changes in metabolic stress markers (serum creatine kinase and blood lactate concentrations)
Before and after agavin supplementation, which lasts 6 weeks
Change in maximal oxygen consumption (VO₂max; mL/kg/min)
before and after the agave treatment, which lasts 6 weeks
Change in body composition
before and after the intervention, which lasts six weeks
Study Arms (1)
agavins
EXPERIMENTALIntervention group that is its own control
Interventions
tomarán 10 g en ayudas diariamente
Eligibility Criteria
You may qualify if:
- athletes in any sport, metabolically healthy.
You may not qualify if:
- intestinal diseases, recreational athletes, people undergoing antibiotic treatment, people undergoing treatment with probiotics or prebiotics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro de Desarrollo de Productos Bióticos
Yautepec, Morelos, 62739, Mexico
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Perla Osorio, SNI II
Centro de Desarrollo de Productos Bióticos
- STUDY DIRECTOR
Brenda H Camacho, Díaz
Centro de Desarrollo de Productos Bióticos
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- phD student
Study Record Dates
First Submitted
August 14, 2026
First Posted
September 18, 2026
Study Start
June 6, 2025
Primary Completion (Estimated)
February 11, 2027
Study Completion (Estimated)
February 11, 2027
Last Updated
September 18, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
De-identified individual participant data underlying the published results will be available. Shared data may include demographic, anthropometric, gut microbiota, short-chain fatty acid, cardiorespiratory fitness, blood biochemical, and statistical analysis data collected before and after the intervention. Personal identifiers will be removed. De-identified data will be available upon reasonable request to the principal investigator for researchers with an approved scientific proposal. Data will be shared after publication of the primary study results.